Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

413
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
413
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

386
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
386
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

293
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
293
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

261
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
261
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

74
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
74
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

283
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
283

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA·2025
Same author

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension.

EClinicalMedicine·2023
Same author

Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning.

Statistics in biopharmaceutical research·2022
Same author

Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluation.

Pharmaceutical statistics·2021
Same author

ACR-ASTRO Practice Parameter for Communication: Radiation Oncology.

American journal of clinical oncology·2020
Same author

ACR-ASTRO Practice Parameter for Image-guided Radiation Therapy (IGRT).

American journal of clinical oncology·2020

Related Experiment Video

Updated: Feb 24, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K

Dose-ranging design and analysis methods to identify the minimum effective dose (MED).

Yijie Zhou1, Su Chen1, Danielle Sullivan1

  • 1Data and Statistical Sciences, AbbVie Inc, 1 N Waukegan Rd, North Chicago, IL 60064, United States.

Contemporary Clinical Trials
|August 19, 2017
PubMed
Summary

Identifying the minimum effective dose (MED) is crucial for clinical trials. This study compares Multiple Comparison Procedures & Modeling (MCP-Mod) with traditional methods for binary outcomes, evaluating MED identification accuracy and precision.

Keywords:
Dose response modelingDunnett's testMCP-ModMinimum effective dose (MED)Trend test

More Related Videos

Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

43.0K
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.2K

Related Experiment Videos

Last Updated: Feb 24, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

43.0K
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.2K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacometrics

Background:

  • Dose-ranging trials are essential for selecting optimal doses for Phase 3 trials by identifying the minimum effective dose (MED).
  • Traditional methods often rely on pairwise comparisons, while Multiple Comparison Procedures & Modeling (MCP-Mod) has emerged as a popular alternative for dose-ranging study design and analysis.
  • Previous comparisons of MCP-Mod with other methods have primarily focused on continuous outcomes under normal distributions.

Purpose of the Study:

  • To extend the comparison of MCP-Mod to binary/binomial response variables in dose-ranging clinical trials.
  • To evaluate the performance of MCP-Mod against traditional methods like Dunnett's test and trend tests in identifying the MED for binary outcomes.
  • To assess the precision of MED estimation using MCP-Mod under various trial design scenarios.

Main Methods:

  • Simulations were conducted to compare the rates of correct and incorrect MED identification.
  • The study examined various dose-response profiles, including both monotone and non-monotone relationships.
  • Different trial design settings were simulated to evaluate performance across diverse scenarios, including trade-offs between dose levels and sample sizes.

Main Results:

  • MCP-Mod demonstrated competitive or superior performance in correctly identifying the minimum effective dose (MED) for binary outcomes compared to Dunnett's test and trend tests across various dose-response profiles.
  • The study identified specific trial design configurations where MCP-Mod offers enhanced precision in MED estimation.
  • Performance varied depending on the underlying dose-response shape and the specific trial design parameters evaluated.

Conclusions:

  • MCP-Mod is a valuable and often more accurate method than traditional approaches for identifying the minimum effective dose (MED) with binary outcomes in dose-ranging trials.
  • The findings provide guidance on optimizing trial designs for precise MED estimation using MCP-Mod.
  • This research supports the broader application of MCP-Mod in clinical trial design for binary endpoints.